PT Combined Imperial Pharmaceuticals (Indonesia)

Combined Imperial Pharmaceuticals is primarily engaged in pharmaceutical preparations activity. Its headquarters is located in Dki Jakarta. The company was founded in 1971. Combined Imperial Pharmaceuticals was established by a group of visionary founders, including Dr. Arif Rahman and Dr. Siti Nurhaliza, who aimed to provide high-quality pharmaceutical products to improve healthcare standards. The company focuses on both primary and secondary business lines, with its primary focus on the development and manufacturing of generic drugs, and a secondary focus on research and development of innovative therapeutic solutions. The company operates several branches across Indonesia, with a strong local geographical footprint in major cities such as Surabaya, Bandung, and Medan. Combined Imperial Pharmaceuticals offers a wide range of products, including antibiotics, cardiovascular drugs, and over-the-counter medications. Some of their well-known product brands include ImpeRx, CardioPlus, and VitaHealth. Internationally, the company has expanded its operations to several countries in Southeast Asia, including Malaysia, Thailand, and the Philippines, enhancing its global geographical footprint. Combined Imperial Pharmaceuticals has established strategic partnerships with international pharmaceutical companies and research institutions to foster innovation and development. The company is a member of several industry associations, such as the Indonesian Pharmaceutical Association and the ASEAN Pharmaceutical Club, which helps it stay at the forefront of industry trends and regulatory changes. Combined Imperial Pharmaceuticals is committed to exporting its products to emerging markets in Africa and the Middle East. With a mission to enhance global health through accessible and affordable medication, the company envisions becoming a leading pharmaceutical provider in the region, driven by innovation, quality, and sustainability.